Cognition Therapeutics Inc. - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

What Alamar Biosciences’ (NASDAQ: ALMR) IPO pop says about the next phase of proteomics investing

UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control

Representative image of Tesco PLC’s supermarket and financial performance theme after the retailer reported £3.15bn adjusted operating profit, record free cash flow, and a new £750m share buyback.

Tesco is the UK’s biggest grocer again — and its FY26 results explain exactly why Aldi and Lidl should be paying attention

Representative image of military and commercial vessels near the Strait of Hormuz, illustrating Iran’s renewed control measures after reversing its brief claim that the waterway was fully open to commercial shipping.

Iran reverses Hormuz opening within 24 hours — IRGC fires on tankers as blockade standoff deepens

Read More

Pharma Industry News

Zervimesine development highlights regulatory complexity in dementia with Lewy bodies

Zervimesine moves closer to Phase 2b as Cognition Therapeutics engages FDA. Read how regulatory complexity is shaping dementia drug development.

bySoujanya Ravi

January 30, 2026

web analytics